Published in IMJ Ill Med J on April 01, 1975
Attempted BCG immunotherapy for condylomata acuminata. Br J Vener Dis (1981) 0.75
Autogenous vaccine therapy for condyloma acuminatum. A double-blind controlled study. Br J Vener Dis (1982) 0.75
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
IgE in pemphigus. Arch Dermatol (1977) 1.09
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Transglutaminase: co-factor in aetiology of AIDS? Lancet (1985) 0.83
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Autoallergy in pemphigus. Lancet (1968) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Selective deficiency of IgA. Lancet (1971) 0.79
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer. Clin Exp Immunol (1979) 0.79
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology (1973) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Experimental concurrence of pemphigus-like autoantibodies and bullous-like lesions. A preliminary report. Jpn J Med Sci Biol (1969) 0.78
Immunofluorescent identification of a human thymic specific antigen. Blut (1974) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues. Gen Physiol Biophys (1999) 0.78
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
Cell-mediated immunity in prostatic cancer. Clin Oncol (1980) 0.78
Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer. Allergol Immunopathol (Madr) (1976) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78
Cellular immunity in bladder cancer patients. J Urol (1978) 0.78
Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls. J Surg Oncol (1974) 0.78
Immunologic studies of patients with pulmonary emphysema. Ann Allergy (1973) 0.78
HIV-related protein in the prostate: a possible reservoir of virus. Am J Clin Pathol (1991) 0.78
Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J Urol (1974) 0.78
Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy. Indian J Exp Biol (1982) 0.78
Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer. JAMA (1972) 0.77
A possible immuno-cryothermic response in prostatic cancer. Clin Radiol (1970) 0.77
Hormonal epidemiology of prostatic cancer. Med J Aust (1977) 0.77
Impotence therapy and cancer of the prostate. Am J Surg (1976) 0.77
Cryoimmunotherapy. Br Med J (1972) 0.77
Malignancy associated with antinuclear antibodies. Lancet (1972) 0.77
Sperm-induced urolithiasis in the rat. Eur J Epidemiol (1994) 0.77
Immunologic studies of the prostate. A review. Int Surg (1969) 0.77
Migration-inhibitory effect of serum from patients with prostatic cancer. Oncology (1974) 0.76
Serum antibody in patients with prostatic cancer. Br J Urol (1976) 0.76
Cryosurgery of the monkey (macaque) prostate. I. Humoral immunologic responsiveness following cryostimulation. Cryobiology (1976) 0.76
On the identification and characterization of prostate-specific antigen. Hum Pathol (1993) 0.76
Serum immunoglobulin E in pemphigus. J Invest Dermatol (1978) 0.76
Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol (1993) 0.76
Prostate-specific antigen: chronology of its identification. Oncology (Williston Park) (1998) 0.76
Pemphigus-like antigens and antibodies in benign and malignant neoplasms. Arch Dermatol Res (1983) 0.75
Possible implications of antisperm antibodies beyond infertility. Urology (1991) 0.75
Immunologic dysfunction in patients with hemophilia. Can Med Assoc J (1984) 0.75
Cryoimmunotherapy: continuing studies toward determining a rational approach for assessing the candidacy of the prostatic cancer patient for cryoimmunotherapy and postoperative responsiveness. An interim report. Cryobiology (1980) 0.75
Prostaglandin E2 affects the tumor immune response in prostatic carcinoma. J Urol (1982) 0.75
The use of cryosurgery for breast cancer. Arch Surg (1998) 0.75
The identification of prostate-specific antigen. Am J Clin Pathol (1991) 0.75
Re: Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol (1998) 0.75
Treatment of recurrent spontaneous abortion: immunization with seminal plasma trophoblast-lymphocyte crossreacting antigen. Am J Reprod Immunol (1989) 0.75
Prostatic acid phosphatase. Br Med J (1971) 0.75
Pathogenesis of AIDS in hemophilia. Ann Allergy (1990) 0.75
Soluble Fc gamma receptors and the maternal-fetal response. J Leukoc Biol (1994) 0.75
The female prostate. J Natl Cancer Inst (1998) 0.75
Antibodies in malignant disease. Br Med J (1972) 0.75
Detection of human immunodeficiency virus in blood or semen by polymerase chain reaction--reliable. Fertil Steril (1993) 0.75
The identification of prostate-specific antigen. J Clin Lab Anal (1991) 0.75
Cryosensitivity. Factors influencing development of immunologic response following cyrosurgery of prostate. Urology (1975) 0.75
What of the clinical significance of the cryoimmune response? Dermatol Surg (1997) 0.75
Biphasic effect of cryosurgery of the prostate on lymphocyte proliferation. Cryobiology (1977) 0.75
Justice versus equity for haemophiliacs with AIDS. BMJ (1990) 0.75